Whatever your question about acquiring Mirada products, contact our sales specialists who are ready to help.
The Executive Management of Mirada Medical Ltd includes the Chief Executive, Hugh Bettesworth and Chief Financial Officer, Gail Buswell in addition to:
![]() |
Dr. Timor Kadir (Chief Scientific & Technology Officer) has over fifteen years experience in industrial and academic research and development all in the fields of image processing and computer vision. He was awarded a Master of Engineering with Distinction in 1995 from the University of Surrey and a Doctorate in Engineering Science from the University of Oxford in 2002. Previously, he worked at Motorola Research working on mobile image and video compression and transmission for 3G and 4G systems. During that time he was author of a number of wireless video transmission ITU standards including H.223M and H.324M. Prior to his current position he was Senior Research Scientist and IP Manager at CTI Mirada Solutions/Siemens Molecular Imaging where he developed and transferred to product a number of image analysis technologies for PET and CT including PET lesion auto-detection and segmentation, registration for cardiac attenuation correction, and PET/CT anatomical feature detection. He has published over 20 papers and holds over 30 patents. He currently holds a Visiting Fellowship at the University of Oxford. |
![]() |
Mary Beth Archibald (Executive Vice President for US Service & Operations) has over 20 years experience in medical imaging, from both clinical and industry settings. She joined CTI Molecular Imaging in 1999 and was instrumental in creating its Market Development program to increase the clinical adoption of PET imaging throughout the US. She oversaw development of four successful outpatient PET imaging centers while at Premier PET Imaging, International, and managed US Operations. Mary Beth returned to CTI and was part of the PETNET team at the time of the Siemens acquisition. She left PETNET to join Accuray, the manufacturer of the CyberKnife, where she managed implementation of robotic radiosurgery technology as an Account Manager. She joined Mirada in September 2009. Mary Beth holds a Bachelor’s degree in Nuclear Medicine from the University of Oklahoma and an MBA from Baker University. |
![]() |
Ian Brown (Chief Engineer) began his career in software development in 1983, working on management information systems. He spent number of years in retail, banking and insurance software development, becoming Principal Engineer and Project Manager. Ian joined Mirada Solutions in 2003 as a Senior Software Engineer, specialising in user interface design. Staying with Mirada during CTI and Siemens acquisitions, Ian joined Mirada Medical as one of the initial group of 4, as Chief Engineer. The Engineering team is responsible for all aspects of product realisation, and regulatory accreditation across global markets. |
|
Stephanie Martinez (US Central Territory Manager) has over 19 years of experience in molecular imaging. Stephanie began her career as a technologist and then managed US Customer Support and Service while at CTI Molecular Imaging. She moved into a Sales Executive position at PETNET, a division of CTI, where she sold some of the earliest versions of Mirada software. After the acquisition by Siemens, Stephanie was a Product Specialist for the Molecular Imaging sales organization. She joined Mirada in May 2009. Stephanie holds a Bachelor’s degree in Agriculture and Nuclear Medicine from the University of Tennessee, Knoxville. |
